Literature DB >> 33806317

An Analysis of the Neurological and Molecular Alterations Underlying the Pathogenesis of Alzheimer's Disease.

Chantal Vidal1, Li Zhang1.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by amyloid beta (Aβ) plaques, neurofibrillary tangles, and neuronal loss. Unfortunately, despite decades of studies being performed on these histological alterations, there is no effective treatment or cure for AD. Identifying the molecular characteristics of the disease is imperative to understanding the pathogenesis of AD. Furthermore, uncovering the key causative alterations of AD can be valuable in developing models for AD treatment. Several alterations have been implicated in driving this disease, including blood-brain barrier dysfunction, hypoxia, mitochondrial dysfunction, oxidative stress, glucose hypometabolism, and altered heme homeostasis. Although these alterations have all been associated with the progression of AD, the root cause of AD has not been identified. Intriguingly, recent studies have pinpointed dysfunctional heme metabolism as a culprit of the development of AD. Heme has been shown to be central in neuronal function, mitochondrial respiration, and oxidative stress. Therefore, dysregulation of heme homeostasis may play a pivotal role in the manifestation of AD and its various alterations. This review will discuss the most common neurological and molecular alterations associated with AD and point out the critical role heme plays in the development of this disease.

Entities:  

Keywords:  Alzheimer’s disease; amyloid beta; heme; mitochondria

Year:  2021        PMID: 33806317      PMCID: PMC7998384          DOI: 10.3390/cells10030546

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  294 in total

1.  Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro.

Authors:  Hanna Ksiezak-Reding; Han Kyoung Pyo; Boris Feinstein; Giulio M Pasinetti
Journal:  Biochim Biophys Acta       Date:  2003-11-20

2.  Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.

Authors:  A Sengupta; J Kabat; M Novak; Q Wu; I Grundke-Iqbal; K Iqbal
Journal:  Arch Biochem Biophys       Date:  1998-09-15       Impact factor: 4.013

3.  APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and a beta 1-40) in familial Alzheimer's disease brain.

Authors:  A Tamaoka; A Odaka; Y Ishibashi; M Usami; N Sahara; N Suzuki; N Nukina; H Mizusawa; S Shoji; I Kanazawa
Journal:  J Biol Chem       Date:  1994-12-30       Impact factor: 5.157

Review 4.  Energetics of functional activation in neural tissues.

Authors:  L Sokoloff
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

5.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease.

Authors:  P Mecocci; U MacGarvey; M F Beal
Journal:  Ann Neurol       Date:  1994-11       Impact factor: 10.422

6.  Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.

Authors:  Z Nagy; M M Esiri; K A Jobst; C Johnston; S Litchfield; E Sim; A D Smith
Journal:  Neuroscience       Date:  1995-12       Impact factor: 3.590

7.  Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death.

Authors:  Moon-Yong Cha; Sun-Ho Han; Sung Min Son; Hyun-Seok Hong; Young-Ju Choi; Jayoung Byun; Inhee Mook-Jung
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

Review 8.  Complement in the pathogenesis of Alzheimer's disease.

Authors:  B Paul Morgan
Journal:  Semin Immunopathol       Date:  2017-11-13       Impact factor: 9.623

Review 9.  The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.

Authors:  Martí Colom-Cadena; Tara Spires-Jones; Henrik Zetterberg; Kaj Blennow; Anthony Caggiano; Steven T DeKosky; Howard Fillit; John E Harrison; Lon S Schneider; Phillip Scheltens; Willem de Haan; Michael Grundman; Christopher H van Dyck; Nicholas J Izzo; Susan M Catalano
Journal:  Alzheimers Res Ther       Date:  2020-03-02       Impact factor: 6.982

View more
  4 in total

Review 1.  Peptides Derived from Growth Factors to Treat Alzheimer's Disease.

Authors:  Suzanne Gascon; Jessica Jann; Chloé Langlois-Blais; Mélanie Plourde; Christine Lavoie; Nathalie Faucheux
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

2.  Nontransgenic Guinea Pig Strains Exhibit Hallmarks of Human Brain Aging and Alzheimer's Disease.

Authors:  Devin Wahl; Julie A Moreno; Kelly S Santangelo; Qian Zhang; Maryam F Afzali; Maureen A Walsh; Robert V Musci; Alyssa N Cavalier; Karyn L Hamilton; Thomas J LaRocca
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-09-01       Impact factor: 6.591

3.  Interaction Interface of Aβ42 with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD.

Authors:  Alexei A Adzhubei; Anna P Tolstova; Maria A Strelkova; Vladimir A Mitkevich; Irina Yu Petrushanko; Alexander A Makarov
Journal:  Biomedicines       Date:  2022-07-11

Review 4.  Neuroinflammation in Alzheimer's Disease.

Authors:  Isaac G Onyango; Gretsen V Jauregui; Mária Čarná; James P Bennett; Gorazd B Stokin
Journal:  Biomedicines       Date:  2021-05-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.